1. Singh AD, Turell ME, Topham AK: Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011, 118(9):1881-1885.
2. Stang A, Parkin DM, Ferlay J, Jockel KH: International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. International journal of cancer 2005, 114(1):114-123.
3. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB: Variates of survival in metastatic uveal melanoma. J Clin Oncol 2005, 23(31):8076-8080.
4. Bol KF, Mensink HW, Aarntzen EH, Schreibelt G, Keunen JE, Coulie PG, de Klein A, Punt CJ, Paridaens D, Figdor CG et al: Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients. American journal of ophthalmology 2014, 158(5):939-947.
5. Hauptman N, Glavac D: Long non-coding RNA in cancer. International journal of molecular sciences 2013, 14(3):4655-4669.
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
7. Li Z, Guo J, Ma Y, Zhang L, Lin Z: Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2. Oncology research 2018, 26(2):219-230.
8. Zhu L, Shu Z, Sun X: Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma. Cancer management and research 2018, 10:2337-2346.
9. Zhou J, Jiang J, Wang S, Xia X: Oncogenic role of microRNA20a in human uveal melanoma. Mol Med Rep 2016, 14(2):1560-1566.
10. Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J: MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Investigative ophthalmology & visual science 2009, 50(4):1559-1565.
11. Zuo Y, Cui Y, Yu G, Li R, Ressom HW: Incorporating prior biological knowledge for network-based differential gene expression analysis using differentially weighted graphical LASSO. BMC bioinformatics 2017, 18(1):99.
12. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P: A postoperative prognostic nomogram for renal cell carcinoma. The Journal of urology 2001, 166(1):63-67.
13. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, McKiernan J, Russo P: A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. The Journal of urology 2005, 173(1):48-51.
14. Qiu J, Peng B, Tang Y, Qian Y, Guo P, Li M, Luo J, Chen B, Tang H, Lu C et al: CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017, 35(7):734-742.
15. Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K: Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. World journal of gastroenterology 2019, 25(2):220-232.
16. Song J, Ye A, Jiang E, Yin X, Chen Z, Bai G, Zhou Y, Liu J: Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC. Journal of cellular biochemistry 2018, 119(8):6665-6673.
17. Joshi P, Kooshki M, Aldrich W, Varghai D, Zborowski M, Singh AD, Triozzi PL: Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells. Clinical & experimental metastasis 2016, 33(8):829-838.
18. Larsen AC, Holst L, Kaczkowski B, Andersen MT, Manfe V, Siersma VD, Kolko M, Kiilgaard JF, Winther O, Prause JU et al: MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma. Acta ophthalmologica 2014, 92(6):541-549.
19. Li Y, Huang Q, Shi X, Jin X, Shen L, Xu X, Wei W: MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1. Chinese medical journal 2014, 127(8):1410-1416.
20. Starkey MP, Compston-Garnett L, Malho P, Dunn K, Dubielzig R: Metastasis-associated microRNA expression in canine uveal melanoma. Veterinary and comparative oncology 2018, 16(1):81-89.
21. Venza M, Dell'Aversana C, Visalli M, Altucci L, Teti D, Venza I: Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines. Tumori 2014, 100(1):e4-7.
22. Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S: Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep 2019.
23. Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, Nitta H, Yoshidome H, Hatano E, Ueno M et al: A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Journal of hepato-biliary-pancreatic sciences 2012, 19(1):72-84.
24. Cao LL, Lu J, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Chen QY, Lin M, Tu RH et al: Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms. World journal of gastroenterology 2017, 23(47):8376-8386.
25. Li J, Gu J, Ma X, Li X, Liu X, Kang F, Xue F: Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer. Journal of surgical oncology 2018, 118(6):1034-1041.
26. Miao DL, Song W, Qian J, Zhu ZG, Wu Q, Lv CG, Chen L: Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors. Translational oncology 2018, 11(5):1097-1103.
27. Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, Turajlic S, Piperno-Neumann S, Grange Pdl, Roman-Roman S et al: SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma. Cancer Discovery 2013(No.10):1122.
28. Maguire S, Leonidou A, Wai P, Marchiò C, Ng C, ... SF3B1 mutations constitute a novel therapeutic target in breast cancer. 《Journal of Pathology》 , 2015 , 235 (4) :571-580 2015.
29. Y K, M K, R. H: Rare SF3B1 R625 mutations in cutaneous melanoma. Melanoma research 2014(No.4):332-334.
30. Malsy M, Graf B, Almstedt K: The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer. BMC biochemistry 2019, 20(1):2.
31. Mitra P: Transcription regulation of MYB: a potential and novel therapeutic target in cancer. Annals of translational medicine 2018, 6(22):443.
32. Stamatakis K, Jimenez-Martinez M, Jimenez-Segovia A, Chico-Calero I, Conde E, Galan-Martinez J, Ruiz J, Pascual A, Barrocal B, Lopez-Perez R et al: Prostaglandins induce early growth response 1 transcription factor mediated microsomal prostaglandin E2 synthase up-regulation for colorectal cancer progression. Oncotarget 2015, 6(37):39941-39959.